Search

A new report from the Second Affiliated Hospital discusses the case of a young woman diagnosed with cervical mullerian adenosarcoma, a rare uterine sarcoma. The patient underwent tumor resection and did not receive adjuvant treatment due to fertility requirements. She has been closely followed up after the operation and has not experienced any relapses. The research suggests that for women with fertility requirements, close follow-ups should be conducted after tumor resection to prevent recurrence, and radical tumor resection should be performed as early as possible once fertility is no longer a concern. [Extracted from the article]

Researchers at West China Second University Hospital conducted a study on Mullerian adenosarcoma, a rare form of cancer that presents diagnostic and therapeutic challenges. The study analyzed the clinicopathological characteristics of 22 adenosarcomas and screened for DICER1 hot mutations. The results showed that only one patient had a DICER1 mutation, highlighting the need for further research into alternative molecular pathways driving this malignancy. The study provides valuable information for understanding the genetic landscape of adenosarcomas. [Extracted from the article]

Keywords: Providence; State:Rhode Island; United States; North and Central America; Adenosarcomas; Cancer; Genetics; Health and Medicine; Mullerian Adenosarcoma; Oncology EN Providence State:Rhode Island United States North and Central America Adenosarcomas Cancer Genetics Health and Medicine Mullerian Adenosarcoma Oncology 931 931 1 03/23/23 20230314 NES 230314 2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology - Mullerian Adenosarcoma is now available. Our news correspondents report that additional information may be obtained by contacting Katrine Hansen, Women and Infants Hospital of Rhode Island, 101 Dudley St, Providence, RI 02905, United States. [Extracted from the article]